文献速递认知障碍与痴呆

晚发性神经精神症状对轻度认知障碍进展为痴呆或恢复正常认知的预测作用

Progression to Dementia or Reversion to Normal Cognition in Mild Cognitive Impairment as a Function of Late-Onset Neuropsychiatric Symptoms.
PubMed 文献 · Neurology · 2022-03-29

研究纳入美国国家阿尔茨海默病协调中心统一数据集中739例轻度认知障碍(MCI)患者,按神经精神症状问卷分为无神经精神症状组(NPS-,409例)和轻度行为损害组(MBI+,330例,即持续晚发性神经精神症状)。随访3年后,MBI+组进展为痴呆的风险显著高于NPS-组(调整比值比[AOR] 2.13,95%CI 1.52-2.99),且恢复正常认知的可能性更低(AOR 0.48,95%CI 0.28-0.83)。仅持续存在的晚发性神经精神症状与恢复正常认知的可能性降低相关。

要点

  • MCI患者中,持续晚发性神经精神症状(MBI)者3年内进展为痴呆的风险是无神经精神症状者的2.13倍(AOR 2.13,95%CI 1.52-2.99)。
  • MBI+组恢复正常认知的可能性低于NPS-组(AOR 0.48,95%CI 0.28-0.83)。
  • 短暂晚发性神经精神症状(NPS_NOT_MBI)者也更易进展为痴呆(AOR 2.18,95%CI 1.56-3.03),但恢复正常认知的可能性与无神经精神症状者无显著差异。

核心结论

  • 晚发性神经精神症状可提高MCI作为痴呆风险状态的预测特异性;但仅持续存在的晚发性神经精神症状与恢复正常认知的可能性降低相关,短暂症状者与无神经精神症状者无差异。
  • 作者认为,将晚发性神经精神症状(尤其是持续存在的MBI)纳入风险评估可改善临床预后判断,临床试验或可从纳入此类高风险MCI患者中获益。

研究设计与样本

  • 研究纳入美国国家阿尔茨海默病协调中心统一数据集中符合MCI诊断的参与者。
  • 使用神经精神症状问卷定义无神经精神症状者(NPS-)和轻度行为损害者(MBI+,即持续晚发性神经精神症状);不符合MBI持续标准的晚发性神经精神症状者(NPS_NOT_MBI)纳入二次分析。
  • 主要样本739例(NPS-组409例,MBI+组330例;年龄75.16±8.6岁,女性40.5%);NPS_NOT_MBI组331例(年龄76.5±8.6岁,女性45.9%)。
  • 随访3年后,依据美国国家衰老研究所-阿尔茨海默病协会标准和Petersen标准判定进展为痴呆、稳定MCI或恢复正常认知。

主要发现

  • 3年随访后,238例(33.6%)进展为痴呆,90例(12.2%)恢复正常认知。
  • MBI+组较NPS-组更可能进展为痴呆(AOR 2.13,95%CI 1.52-2.99),年进展率为14.7% vs 8.3%。
  • MBI+组较NPS-组恢复正常认知的可能性更低(AOR 0.48,95%CI 0.28-0.83),年恢复率为2.5% vs 5.3%。
  • NPS_NOT_MBI组较NPS-组更可能进展为痴呆(AOR 2.18,95%CI 1.56-3.03),年进展率14.3%,但恢复正常认知的可能性未显著低于NPS-组。
  • 3年后,NPS_NOT_MBI组和MBI+组的简易精神状态检查评分均低于NPS-组。

临床怎么用

  • 作者认为,临床预后判断可将晚发性神经精神症状(尤其是持续存在的MBI)纳入风险评估。
  • 作者认为,临床试验或可从纳入这些较高风险的MCI患者中获益。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Mild cognitive impairment (MCI) is an at-risk state for dementia; however, not all individuals with MCI transition to dementia, and some revert to normal cognition (NC). Here, we investigate whether mild behavioral impairment (MBI), the late-life onset of persistent neuropsychiatric symptoms (NPS), improves the prognostic specificity of MCI. METHODS: Participants with MCI from the National Alzheimer's Coordinating Center Uniform Data Set were included. NPS were operationalized with the Neuropsychiatric Inventory Questionnaire to identify participants without NPS and those with MBI (persistent, late-onset NPS). Individuals with late-onset NPS not meeting the MBI persistence criterion (NPS_NOT_MBI) were retained for secondary analyses. Progression to dementia, stable MCI, and reversion to NC after 3 years of follow-up were defined per National Institute on Aging-Alzheimer's Association and Petersen criteria. RESULTS: The primary sample consisted of 739 participants (NPS- n = 409 and MBI+ n = 330; 75.16 ± 8.6 years old, 40.5% female). After 3 years, 238 participants (33.6%) progressed to dementia, and 90 (12.2%) reverted to NC. Compared to participants without NPS, participants with MBI were significantly more likely to progress to dementia (adjusted odds ratio [AOR] 2.13, 95% CI 1.52-2.99), with an annual progression rate of 14.7% (vs 8.3% for participants with MCI without NPS). Compared to participants without NPS, participants with MBI were less likely to revert to NC (AOR 0.48, 95% CI 0.28-0.83, 2.5% vs 5.3% annual reversion rate). The NPS_NOT_MBI group (n = 331, 76.5 ± 8.6 years old, 45.9% female) were more likely to progress to dementia (AOR 2.18, 95% CI 1.56-3.03, 14.3% annual progression rate) but not less likely to revert to NC than those without NPS. Accordingly, both NPS_NOT_MBI and MBI+ participants had lower Mini-Mental State Examination scores than NPS- participants after 3 years. DISCUSSION: Late-onset NPS improve the specificity of MCI as an at-risk state for progression to dementia. However, only persistent late-onset NPS are associated with a lower likelihood of reversion to NC, with transient NPS (i.e., NPS_NOT_MBI) not differing from the NPS- group. Clinical prognostication can be improved by incorporating late-onset NPS, especially those that persist (i.e., MBI), into risk assessments. Clinical trials may benefit from enrichment with these higher-risk participants with MCI.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. McGirr A, Nathan S, Ghahremani M, et al. Progression to Dementia or Reversion to Normal Cognition in Mild Cognitive Impairment as a Function of Late-Onset Neuropsychiatric Symptoms. Neurology. 2022. PMID: 35351783. doi:10.1212/WNL.0000000000200256

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。